(2E)-3-(2,4-dichlorophenyl)-1-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

tert-Butyl (3-chloropyridin-2-yl)carbamate, 97%, 250mg

7-(((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-7-oxoheptanoic acid, 97%, 50mg

trans-N,N'-Dimethylcyclohexane-1,2-diamine>98.0%(T)5g

((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane, 97%, 1g

Methyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 25g

N-Methyl-N,O-bis(trimethylsilyl)hydroxylamine5mL

1-Pyridin-4-yl-piperidine-3-carboxylic acid, 98.0%, 250mg

3-Phenyl-8-(phenylmethyl)-8-azabicyclo[3.2.1]octan-3-ol, 97%, 1g

4-Bromo-3-methoxy-1H-indazole, 95.0%, 1g

7-(TRIFLUOROMETHYL)-2,3-DIHYDROQUINAZOLIN-4(1H)-ONE, 95.0%, 100mg

5-Chlorobenzo[c]isoxazole, 95.0%, 100mg

Methyl 2-(triphenylphosphoranylidene)propanoate, 95.0%, 250mg